Log in

ARBS Arterra Bioscience SpA MIL · Italy

Arterra Bioscience SpA (ARBS) news

Arterra Bioscience SpA is a public biotech or pharmaceutical company listed on MIL under the ticker ARBS, recorded under Italy. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Arterra Bioscience SpA news

We have not published a story on Arterra Bioscience SpA yet. When there is news, it will appear here.

Questions about Arterra Bioscience SpA

What is the ticker symbol of Arterra Bioscience SpA?

Arterra Bioscience SpA trades under the ticker ARBS on MIL.

Where is Arterra Bioscience SpA listed?

Arterra Bioscience SpA is listed on MIL.

Which country or territory is Arterra Bioscience SpA listed under?

Our directory records Arterra Bioscience SpA under Italy.

What does Arterra Bioscience SpA do?

Our directory classifies Arterra Bioscience SpA as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Arterra Bioscience SpA?

The ISIN recorded for Arterra Bioscience SpA is IT0005386369.

Does aibio.space cover Arterra Bioscience SpA?

aibio.space lists Arterra Bioscience SpA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Arterra Bioscience SpA?

Companies in our directory listed in the same country and business area as Arterra Bioscience SpA: Philogen SpA, Fine Foods & Pharmaceuticals N.T.M. SpA, Recordati S.p.A., Newron Pharmaceuticals S.p.A..

Investor discussion: Arterra Bioscience SpA

Members talk about Arterra Bioscience SpA (ARBS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open MIL:ARBS on TradingView.

Listing details

Arterra Bioscience SpA is a public biotech or pharmaceutical company listed on MIL under the ticker ARBS, recorded under Italy. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Arterra Bioscience SpA
Ticker
ARBS
Listing
MIL
Country or territory
Italy
Business scope
Biotechnology
ISIN
IT0005386369
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.